Amneal Pharmaceuticals recalled four lots of vancomycin hydrochloride for oral solution, an enterocolitis treatment, because some bottles might be overfilled, the FDA said March 27. The next day, the agency published a voluntary recall from Eugia US. The drugmaker recalled one lot of its methocarbamol injection after a customer reported “the presence of white particles floating inside of the vial,” the FDA said.
The medicine is indicated for discomfort connected to acute, painful musculoskeletal conditions.
On April 1, Pulaski, Tenn.-based AvKARE pulled one lot of atovaquone oral suspension after a third-party lab discovered a potential Bacillus cereus contamination.
Atovaquone is used to Pneumocystis jirovecii pneumonia in patients 13 and older who cannot tolerate other medicines, according to the FDA.
Amid the three recalls, zero adverse events have been reported.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
